Delivery Order SPE2DB22D2211-SPE2DB25FRVFR
Award Date
4/14/25
Potential Completion Date
5/5/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,118.08, is a delivery order for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract has a performance period through April 14, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,061.38 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,061.38, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a $8,118.08 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, with a performance period through July 15, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $8,118.08 and a completion date of April 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This is a $16,236.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of IBRANCE 125MG CAP 21S, a specialty medication. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 11, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
This federal contract award, valued at $8,061.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with an ultimate completion date of February 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,236.16 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,065.75 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through February 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,484.74 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a prescription pharmaceutical product. The contract has an ultimate completion date of November 21, 2023 and was awarded on October 30, 2023. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...